for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Novartis Says Following two Recent Patient Fatalities In Zolgensma Gene Therapy, Co Will Update Labeling To Specify Fatal Acute Liver Failure Reported

Aug 11 (Reuters) - Novartis AG:

* NOVARTIS - FOLLOWING 2 RECENT PATIENT FATALITIES IN ZOLGENSMA GENE THERAPY CO WILL BE UPDATING LABELING TO SPECIFY FATAL ACUTE LIVER FAILURE REPORTED Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up